They redesigned PubMed, a beloved web site. It hasn’t gone over properly

They redesigned PubMed, a beloved website. It hasn’t gone over well



Tero Vesalainen/Istockphoto, tailored by M. Atarod/Science

PubMed, the huge database of biomedical literature maintained by the U.S. Nationwide Heart for Biotechnology Data (NCBI), is among the U.S. authorities’s hottest web sites, with some 2 million customers every day. So when one thing at PubMed modifications, it doesn’t go unnoticed.

Sadly for the positioning’s caretakers, nevertheless, a sweeping redesign unveiled this week has left many PubMed customers fuming—and airing their generally curse-laden complaints on social media.

“Am I the one one who hates the brand new PubMed?” tweeted @LCneuroscience, the laboratory of David Weinshenker, a geneticist on the Emory College College of Drugs, on 19 Might, the day after NCBI rolled out its remake.

“No. Hate at first sight. Additionally second and third,” replied biologist David Suter of the Swiss Federal Institute of Know-how Lausanne, in simply one in all a whole bunch of comparable tweets that rapidly got here in response—some unprintable on family-friendly web sites. And by 22 Might, the unique tweet from the Weinshenker lab had racked up greater than 1600 likes.

Most of the complainers decry PubMed’s new styling and format, the best way it shows search outcomes, and its supposedly enhanced search algorithms. “HERE’S THE NEW PUBMED YOU DIDN’T ASK FOR. IT’S GOING TO MAKE YOUR EYES BLEED AND KILL YOUR SOUL. #bringbackoldpubmed,” tweeted Paul Jenkins, a molecular biologist on the College of Michigan Medical College.

The Drug Monkey weblog had a extra particular criticism:

Molecular biologist Richard Ebright, in the meantime, urged PubMed customers to demand a return to an older model:

Others provided a extra nuanced take, noting that just about each redesign of a preferred web site is initially criticized earlier than individuals be taught to dwell with it.

When requested to touch upon such suggestions, a spokesperson for the Nationwide Library of Drugs, which encompasses NCBI, directed ScienceInsider to NLM weblog posts in regards to the redesign. They word the remake aimed to supply PubMed customers with a contemporary interface, simpler navigation, and higher search outcomes primarily based on machine studying algorithms. And in a January put up, Bart Trawick, NCBI’s director of buyer companies, famous that: “Whether or not you suppose the brand new model of PubMed is the bee’s knees simply the best way it’s, or you will have a terrific perception on the way to make it higher—we will likely be ready to listen to from you.”

That wait is outwardly over. And on 21 Might, NLM Director Patricia Brennan took to Twitter to encourage PubMed customers to document their ideas on its suggestions type. The company understands customers could also be experiencing “some points” with the transition, she wrote. In consequence, it’s now contemplating offering “short-term entry” to PubMed’s legacy, preimproved model.

Supply hyperlink

This site uses Akismet to reduce spam. Learn how your comment data is processed.